Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

HQL vs THQ: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HQL Captures Overall Composite Edge (46.0 HOLD vs 45.8 HOLD), While THQ Leads 1–0 on Growth & Valuation Pillars

HQL Overall Winner 6-Pillar Tally: HQL 0 – 1 THQ (5 Tie) Matrix Metrics: HQL 1 – 3 THQ

As of Nov 16, 2026, abrdn Life Sciences Investors (HQL) captures the overall head-to-head institutional edge over abrdn Healthcare Opportunities Fund (THQ) on higher Unified Composite conviction (46.0/100 HOLD vs. 45.8/100 HOLD) after splitting the core matrix 1–3 (led by composite factor balance), while THQ wins 1–0 across the 6-pillar growth and valuation breakdown. HQL trades at $17.81 (N/M Forward P/E, N/A operating margin) versus THQ at $18.89 (N/M Forward P/E, N/A operating margin).

  • Growth vs. Quality Trade-Off: HQL earns the overall head-to-head edge with a stronger Unified Composite Score (46.0/100 HOLD vs. THQ 45.8/100 HOLD) and 0.91β · 39% Vol risk profile, whereas THQ leads top-line expansion (N/A YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About HQL vs THQ
HQL NYSE Head-to-Head Winner
abrdn Life Sciences Investors
Institutional Equity
$17.81
-2.57% 1D
Market Cap $455.0M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.91β · 39% Vol
Unified Composite Score
46.0 / 100 HOLD
Tech 48.0 Fund 52.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 46
RSI-14: 45.5 · SMA20: $18.16 · SMA50: $18.45
THQ NYSE
abrdn Healthcare Opportunities Fund
Institutional Equity
$18.89
-0.79% 1D
Market Cap $734.5M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.53β · 24% Vol
Unified Composite Score
45.8 / 100 HOLD
Tech 39.0 Fund 38.0 Flow 50.0 Mom 22.3
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 53
RSI-14: 52.9 · SMA20: $18.78 · SMA50: $18.57

6-Pillar Scorecard Institutional Category Breakdown (HQL 0 – 1 THQ)

Columns: Metric · HQL · THQ
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale THQ
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap $455.0M $734.5M
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: HQL (1) vs THQ (3)
Institutional Metric HQL THQ Criterion Row Edge
Market Capitalization
Scale
$455.0M $734.5M Larger Scale THQ
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
31% ($16–$23) 64% ($16–$20) Stronger Trend THQ
Beta / 30D Volatility
Risk Regime
0.91β · 39% Vol 0.53β · 24% Vol Lower Realized Risk THQ
Unified Institutional Score
Composite Signal
46.0 / 100 (HOLD) 45.8 / 100 (HOLD) Higher Composite HQL
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HQL +0.79 pp
HQL: +6.14% · THQ: +5.35%
3M Horizon THQ +14.72 pp
HQL: -18.0% · THQ: -3.28%
6M Horizon THQ +2.1 pp
HQL: +0.79% · THQ: +2.89%
1Y Horizon HQL +2.41 pp
HQL: +6.2% · THQ: +3.79%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HQL vs THQ. Trailing 12-month operating profitability (HQL N/A vs THQ N/A) and valuation multiples (HQL N/M vs THQ N/M Forward P/E) are benchmarked directly in Pillar 4 below.

HQL ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
THQ ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
HQL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact HQL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
THQ UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact THQ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
HQL Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $455.0M market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
THQ Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $734.5M market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ HQL vs THQ Key Questions & Quantitative Answers

As of Nov 16, 2026, abrdn Life Sciences Investors (HQL) captures the overall head-to-head institutional edge over abrdn Healthcare Opportunities Fund (THQ) on higher Unified Composite conviction (46.0/100 HOLD vs. 45.8/100 HOLD) after splitting the core matrix 1–3 (led by composite factor balance), while THQ wins 1–0 across the 6-pillar growth and valuation breakdown. HQL trades at $17.81 (N/M Forward P/E, N/A operating margin) versus THQ at $18.89 (N/M Forward P/E, N/A operating margin). Growth vs. Quality Trade-Off: HQL earns the overall head-to-head edge with a stronger Unified Composite Score (46.0/100 HOLD vs. THQ 45.8/100 HOLD) and 0.91β · 39% Vol risk profile, whereas THQ leads top-line expansion (N/A YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.

THQ leads the Growth & Scale pillar: HQL posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with THQ at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, HQL generates N/A in USD-normalized revenue versus N/A for THQ. In operating R&D and SG&A reinvestment, HQL deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for THQ.

HQL and THQ trade at balanced relative valuation multiples. HQL trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas THQ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HQL (N/A ROE) versus THQ (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, HQL carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.91β · 39% Vol realized risk). By comparison, THQ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.53β · 24% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.